Pfizer Says COVID-19 Vaccine Protection Lasts at Least 6 Months.<br />Pfizer and BioNTech announced that their ongoing <br />Phase 3 clinical vaccine trial confirms protection <br />for at least six months after the second dose.<br />The vaccine was also shown to be effective <br />in protecting against the B.1.351 variant, <br />which originated in South Africa.<br />The Pfizer/BioNTech vaccine remains<br />more than 91% effective against <br />being infected with any symptoms. .<br />These data confirm the <br />favorable efficacy and safety <br />profile of our vaccine.., Pfizer chairman and CEO Albert Bourla, via statement.<br />... and position us to submit a Biologics License Application (BLA) <br />to the U.S. FDA, Pfizer chairman and CEO Albert Bourla, via statement.<br />A BLA would put the vaccine, which is <br />currently under emergency use authorization,<br />in the running for full approval
